nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—Hyperventilation—Niacin—atherosclerosis	0.0295	0.0805	CcSEcCtD
Pralidoxime—Inflammation—Ezetimibe—atherosclerosis	0.0239	0.0652	CcSEcCtD
Pralidoxime—Inflammation—Simvastatin—atherosclerosis	0.0228	0.0622	CcSEcCtD
Pralidoxime—Muscular weakness—Rosuvastatin—atherosclerosis	0.0178	0.0487	CcSEcCtD
Pralidoxime—Muscular weakness—Ezetimibe—atherosclerosis	0.0148	0.0405	CcSEcCtD
Pralidoxime—Diplopia—Pravastatin—atherosclerosis	0.0145	0.0396	CcSEcCtD
Pralidoxime—Muscular weakness—Simvastatin—atherosclerosis	0.0141	0.0386	CcSEcCtD
Pralidoxime—Muscular weakness—Niacin—atherosclerosis	0.013	0.0354	CcSEcCtD
Pralidoxime—Muscular weakness—Pravastatin—atherosclerosis	0.0128	0.0349	CcSEcCtD
Pralidoxime—Haemoglobin—Niacin—atherosclerosis	0.0102	0.0279	CcSEcCtD
Pralidoxime—Haemorrhage—Niacin—atherosclerosis	0.0102	0.0278	CcSEcCtD
Pralidoxime—Vision blurred—Lovastatin—atherosclerosis	0.00973	0.0266	CcSEcCtD
Pralidoxime—Vision blurred—Simvastatin—atherosclerosis	0.0091	0.0248	CcSEcCtD
Pralidoxime—Pain—Rosuvastatin—atherosclerosis	0.0085	0.0232	CcSEcCtD
Pralidoxime—Vision blurred—Niacin—atherosclerosis	0.00836	0.0228	CcSEcCtD
Pralidoxime—Vision blurred—Pravastatin—atherosclerosis	0.00823	0.0225	CcSEcCtD
Pralidoxime—Pain—Lovastatin—atherosclerosis	0.00721	0.0197	CcSEcCtD
Pralidoxime—Pain—Ezetimibe—atherosclerosis	0.00707	0.0193	CcSEcCtD
Pralidoxime—Tachycardia—Niacin—atherosclerosis	0.00706	0.0193	CcSEcCtD
Pralidoxime—Pain—Simvastatin—atherosclerosis	0.00674	0.0184	CcSEcCtD
Pralidoxime—Dizziness—Rosuvastatin—atherosclerosis	0.00658	0.0179	CcSEcCtD
Pralidoxime—Somnolence—Niacin—atherosclerosis	0.00643	0.0176	CcSEcCtD
Pralidoxime—Headache—Rosuvastatin—atherosclerosis	0.00623	0.017	CcSEcCtD
Pralidoxime—Pain—Niacin—atherosclerosis	0.00619	0.0169	CcSEcCtD
Pralidoxime—Pain—Pravastatin—atherosclerosis	0.00609	0.0166	CcSEcCtD
Pralidoxime—Nausea—Rosuvastatin—atherosclerosis	0.00591	0.0161	CcSEcCtD
Pralidoxime—Dizziness—Lovastatin—atherosclerosis	0.00557	0.0152	CcSEcCtD
Pralidoxime—Dizziness—Ezetimibe—atherosclerosis	0.00547	0.0149	CcSEcCtD
Pralidoxime—Headache—Lovastatin—atherosclerosis	0.00528	0.0144	CcSEcCtD
Pralidoxime—Dizziness—Simvastatin—atherosclerosis	0.00521	0.0142	CcSEcCtD
Pralidoxime—Headache—Ezetimibe—atherosclerosis	0.00518	0.0141	CcSEcCtD
Pralidoxime—Nausea—Lovastatin—atherosclerosis	0.00501	0.0137	CcSEcCtD
Pralidoxime—Headache—Simvastatin—atherosclerosis	0.00494	0.0135	CcSEcCtD
Pralidoxime—Nausea—Ezetimibe—atherosclerosis	0.00491	0.0134	CcSEcCtD
Pralidoxime—Dizziness—Niacin—atherosclerosis	0.00479	0.0131	CcSEcCtD
Pralidoxime—Dizziness—Pravastatin—atherosclerosis	0.00471	0.0129	CcSEcCtD
Pralidoxime—Nausea—Simvastatin—atherosclerosis	0.00468	0.0128	CcSEcCtD
Pralidoxime—ACHE—Phospholipid metabolism—PLA2G1B—atherosclerosis	0.00462	0.00729	CbGpPWpGaD
Pralidoxime—Headache—Niacin—atherosclerosis	0.00453	0.0124	CcSEcCtD
Pralidoxime—Headache—Pravastatin—atherosclerosis	0.00446	0.0122	CcSEcCtD
Pralidoxime—BCHE—Peptide hormone metabolism—GHRL—atherosclerosis	0.00444	0.00702	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—ACE—atherosclerosis	0.0043	0.00679	CbGpPWpGaD
Pralidoxime—Nausea—Niacin—atherosclerosis	0.0043	0.0117	CcSEcCtD
Pralidoxime—Nausea—Pravastatin—atherosclerosis	0.00423	0.0116	CcSEcCtD
Pralidoxime—ACHE—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.00421	0.00665	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—IL1B—atherosclerosis	0.00417	0.00659	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PLA2G1B—atherosclerosis	0.00412	0.0065	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—ESR1—atherosclerosis	0.00383	0.00605	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—NOS2—atherosclerosis	0.00374	0.0059	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—INS—atherosclerosis	0.00343	0.00541	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.0033	0.00521	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00326	0.00514	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MMP2—atherosclerosis	0.00321	0.00507	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.0031	0.0049	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—AGT—atherosclerosis	0.00306	0.00483	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TNF—atherosclerosis	0.00303	0.00478	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—LEP—atherosclerosis	0.003	0.00473	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00294	0.00465	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IFNG—atherosclerosis	0.00287	0.00453	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00277	0.00437	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—AGT—atherosclerosis	0.00273	0.00431	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00269	0.00425	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00269	0.00425	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—LEP—atherosclerosis	0.00267	0.00422	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CXCL8—atherosclerosis	0.00267	0.00421	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—INS—atherosclerosis	0.00256	0.00404	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—IGF1—atherosclerosis	0.00248	0.00391	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00247	0.0039	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.0024	0.00379	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.0024	0.00379	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK8—atherosclerosis	0.00235	0.0037	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—INS—atherosclerosis	0.00228	0.00361	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—IGF1—atherosclerosis	0.00221	0.00349	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00213	0.00336	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK3—atherosclerosis	0.00205	0.00323	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.002	0.00316	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.002	0.00316	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.00199	0.00314	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00196	0.0031	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00193	0.00304	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.0019	0.00299	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CG—atherosclerosis	0.00184	0.0029	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00178	0.00282	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00178	0.00282	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00178	0.00281	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.00177	0.0028	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.00175	0.00277	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00175	0.00276	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00172	0.00271	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00169	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00169	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00169	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00169	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00167	0.00263	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CG—atherosclerosis	0.00164	0.00258	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00161	0.00254	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLA2G7—atherosclerosis	0.00161	0.00254	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00159	0.00251	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.00156	0.00247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00155	0.00244	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00151	0.00238	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00151	0.00238	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00151	0.00238	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00151	0.00238	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—atherosclerosis	0.0015	0.00237	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.0015	0.00236	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00149	0.00235	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00149	0.00235	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LDLRAP1—atherosclerosis	0.00147	0.00232	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00144	0.00227	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLA2G7—atherosclerosis	0.00144	0.00227	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00144	0.00227	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLTP—atherosclerosis	0.00138	0.00218	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00138	0.00218	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCG—atherosclerosis	0.00134	0.00212	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00133	0.00209	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LDLRAP1—atherosclerosis	0.00131	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPD1—atherosclerosis	0.00131	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.0013	0.00205	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00128	0.00202	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00128	0.00202	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00127	0.00201	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00126	0.002	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00124	0.00195	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLTP—atherosclerosis	0.00123	0.00195	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCG—atherosclerosis	0.0012	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LTA4H—atherosclerosis	0.0012	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG8—atherosclerosis	0.0012	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00118	0.00187	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPD1—atherosclerosis	0.00117	0.00184	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00114	0.0018	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00114	0.00179	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00113	0.00178	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00112	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.0011	0.00174	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.00107	0.0017	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG8—atherosclerosis	0.00107	0.00169	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LTA4H—atherosclerosis	0.00107	0.00169	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—F7—atherosclerosis	0.00106	0.00167	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00106	0.00167	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000997	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000996	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG1—atherosclerosis	0.000947	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—F7—atherosclerosis	0.000942	0.00149	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GHRL—atherosclerosis	0.000941	0.00148	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000933	0.00147	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000917	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACE—atherosclerosis	0.000911	0.00144	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FABP4—atherosclerosis	0.00089	0.00141	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LCAT—atherosclerosis	0.00089	0.00141	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000888	0.0014	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA4—atherosclerosis	0.000874	0.00138	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP7A1—atherosclerosis	0.000859	0.00136	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000846	0.00134	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG1—atherosclerosis	0.000845	0.00133	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GHRL—atherosclerosis	0.000839	0.00132	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLAUR—atherosclerosis	0.000818	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000818	0.00129	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACE—atherosclerosis	0.000813	0.00128	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000801	0.00126	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLG—atherosclerosis	0.0008	0.00126	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FABP4—atherosclerosis	0.000794	0.00125	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LCAT—atherosclerosis	0.000794	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP27A1—atherosclerosis	0.000794	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000781	0.00123	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA4—atherosclerosis	0.00078	0.00123	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000777	0.00123	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP7A1—atherosclerosis	0.000766	0.00121	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000762	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLA2G2A—atherosclerosis	0.000752	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA2—atherosclerosis	0.000752	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALOX5AP—atherosclerosis	0.000752	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALOX15—atherosclerosis	0.000752	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG5—atherosclerosis	0.000743	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000742	0.00117	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	0.00073	0.00115	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.00073	0.00115	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF2—atherosclerosis	0.000728	0.00115	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000725	0.00115	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPA—atherosclerosis	0.000718	0.00113	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLG—atherosclerosis	0.000714	0.00113	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP27A1—atherosclerosis	0.000708	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000697	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BGN—atherosclerosis	0.000695	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00069	0.00109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA5—atherosclerosis	0.000688	0.00109	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.00068	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA2—atherosclerosis	0.000671	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLA2G2A—atherosclerosis	0.000671	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALOX5AP—atherosclerosis	0.000671	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALOX15—atherosclerosis	0.000671	0.00106	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000668	0.00105	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG5—atherosclerosis	0.000663	0.00105	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLA2G1B—atherosclerosis	0.000662	0.00105	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000662	0.00105	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000655	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF2—atherosclerosis	0.00065	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000649	0.00102	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000647	0.00102	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPA—atherosclerosis	0.00064	0.00101	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALOX5—atherosclerosis	0.00064	0.00101	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—BGN—atherosclerosis	0.00062	0.000979	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000616	0.000972	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA5—atherosclerosis	0.000614	0.000969	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000596	0.000941	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000591	0.000933	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLA2G1B—atherosclerosis	0.000591	0.000933	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP1—atherosclerosis	0.000585	0.000923	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000584	0.000922	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000579	0.000914	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000578	0.000912	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—AGT—atherosclerosis	0.000578	0.000912	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NAMPT—atherosclerosis	0.000574	0.000906	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALOX5—atherosclerosis	0.000571	0.000901	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00057	0.0009	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LIPC—atherosclerosis	0.00057	0.0009	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOC3—atherosclerosis	0.000567	0.000894	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LEP—atherosclerosis	0.000566	0.000893	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LDLR—atherosclerosis	0.000563	0.000889	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CETP—atherosclerosis	0.00055	0.000868	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.00054	0.000852	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—F2—atherosclerosis	0.000534	0.000842	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000527	0.000832	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SCARB1—atherosclerosis	0.000527	0.000831	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP1—atherosclerosis	0.000522	0.000823	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—AGT—atherosclerosis	0.000515	0.000813	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000513	0.00081	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NAMPT—atherosclerosis	0.000512	0.000808	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000509	0.000803	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LIPC—atherosclerosis	0.000509	0.000803	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOC3—atherosclerosis	0.000506	0.000798	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LEP—atherosclerosis	0.000505	0.000797	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LDLR—atherosclerosis	0.000502	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMGCR—atherosclerosis	0.000498	0.000785	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CETP—atherosclerosis	0.000491	0.000775	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—INS—atherosclerosis	0.000483	0.000763	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—F2—atherosclerosis	0.000476	0.000751	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCL2—atherosclerosis	0.000476	0.000751	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SCARB1—atherosclerosis	0.00047	0.000742	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—atherosclerosis	0.000468	0.000738	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000458	0.000722	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—atherosclerosis	0.000453	0.000714	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000449	0.000708	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMGCR—atherosclerosis	0.000444	0.000701	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCA1—atherosclerosis	0.000443	0.0007	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—INS—atherosclerosis	0.000431	0.000681	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCL2—atherosclerosis	0.000424	0.00067	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—atherosclerosis	0.000417	0.000658	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—atherosclerosis	0.000404	0.000637	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.0004	0.000632	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCA1—atherosclerosis	0.000396	0.000624	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—atherosclerosis	0.00038	0.0006	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000376	0.000594	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOB—atherosclerosis	0.000364	0.000575	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—atherosclerosis	0.000354	0.00056	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPL—atherosclerosis	0.000348	0.000549	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX1—atherosclerosis	0.000339	0.000536	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—atherosclerosis	0.000339	0.000536	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000335	0.00053	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CD36—atherosclerosis	0.000331	0.000522	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOB—atherosclerosis	0.000325	0.000513	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—atherosclerosis	0.000316	0.000499	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—atherosclerosis	0.000313	0.000494	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPL—atherosclerosis	0.00031	0.00049	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARA—atherosclerosis	0.000307	0.000485	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX1—atherosclerosis	0.000303	0.000478	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AGT—atherosclerosis	0.000298	0.00047	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CD36—atherosclerosis	0.000295	0.000466	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOE—atherosclerosis	0.000292	0.00046	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAV1—atherosclerosis	0.000289	0.000456	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA1—atherosclerosis	0.000288	0.000455	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—atherosclerosis	0.000279	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARA—atherosclerosis	0.000274	0.000433	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AGT—atherosclerosis	0.000266	0.000419	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—atherosclerosis	0.000263	0.000415	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOE—atherosclerosis	0.00026	0.000411	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAV1—atherosclerosis	0.000258	0.000407	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA1—atherosclerosis	0.000257	0.000406	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARG—atherosclerosis	0.000254	0.000401	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INS—atherosclerosis	0.000249	0.000393	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—atherosclerosis	0.000235	0.000371	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—atherosclerosis	0.000228	0.000361	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARG—atherosclerosis	0.000227	0.000358	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INS—atherosclerosis	0.000222	0.000351	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—atherosclerosis	0.000219	0.000345	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—atherosclerosis	0.000204	0.000322	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—atherosclerosis	0.0002	0.000315	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—atherosclerosis	0.000195	0.000308	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—atherosclerosis	0.000178	0.000281	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—atherosclerosis	0.0001	0.000159	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—atherosclerosis	8.96e-05	0.000141	CbGpPWpGaD
